XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
183 hedge funds and large institutions have $2.57B invested in Acceleron Pharma in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 61 increasing their positions, 60 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 172 → 183 (+11)
2% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 60
Holders
183
Holding in Top 10
6
Calls
$20.4M
Puts
$10.4M
Top Buyers
| 1 | +$107M | |
| 2 | +$49.6M | |
| 3 | +$17.1M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.8M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$7.24M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$21.2M | |
| 3 | -$19.4M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$15.9M |
| 5 |
BlackRock
New York
|
-$15.3M |